Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic prophylaxis in breast reconstruction with implants
2012-004878-26Phase 4Withdrawn
- Sponsor
- Karolinska University Hospital
- Start
- Nov 2012
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cloxacillin and clindamycin in breast cancer (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Postoperative infection. Planned start Nov 2012; status: withdrawn.
02
Drugs
cloxacillinclindamycin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-004878-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004878-26.